Using NCID Database to Assess the Safety of Olaparib in Chinese Patients With Ovarian Cancer by Examining the Incidence, Seriousness, and Severity of All AE
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Assessment of Safety of Olaparib in Chinese Patients With Ovarian Cancer in the Real-World Setting (NCT06324734) | AstraZeneca | 2024-04-29 |
Track Using NCID Database to Assess the Safety of Olaparib in Chinese Patients With Ovarian Cancer by Examining the Incidence, Seriousness, and Severity of All AE automatically
Every clearance here is in the API, with alerts when new ones post.